Hybrid Advertising Campaign Wins Jersey Awards Honor
June 6, 2008
BioTek’s Hybrid Technology Campaign introduced an entirely new class of multi-mode microplate readers to drug discovery and life science markets. Tactics within the Hybrid Technology campaign, including print and electronic advertising, a short animated movie, technical illustrations, tradeshow materials and events, promotions and technical articles, all served to closely align this new Hybrid class with BioTek’s Synergy 4 – the only product in the category.
The patent-pending Synergy 4 Multi-Mode Microplate Reader combines filter-based and quadruple monochromator-based fluorescence detection technology to perform an unlimited number of microplate-based assays. This combination provides for endless flexibility in current and future microplate-based assay choice. Synergy 4 also includes Fluorescence Intensity, Luminescence, Fluorescence Polarization, Time-Resolved Fluorescence, AlphaScreen® and UV-Visible Absorbance.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research. Founded in 1968, BioTek Instruments is celebrating its 40th anniversary this year.
For further information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications